SPC463
Ómaveloxólón eða lyfjafræðilega viðunandi salt þar af
Status:
VeittApplication date:
16.4.2024Application published:
15.5.2024Grant published:
15.12.2025
Max expiry date:
23.4.2038Medicine name:
SkyclarysMedicine for children:
No
Timeline
Today
16.4.2024Application
15.5.2024Publication
15.12.2025Registration
23.4.2038Expires
Marketing license
IS authorization number:
EU/1/23/1786Date:
11.3.2024
Foreign authorization number:
EU/1/23/1786Date:
9.2.2024
Owner
Name:
Reata Pharmaceuticals Holdings, LLCAddress:
5320 Legacy Drive, Plano, Texas 75024 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2841445
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025